Paper40280545
Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.
Kalra A and 16 others. Am J Obstet Gynecol, 2025. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis. Papers, record 40280545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40280545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Uptake and patient-related outcomes of mainstreaming genetic testing: a systematic review and meta-analysis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Testing | Major topic |
| Patient Reported Outcome Measures | Major topic |
| Neoplasms | Major topic |
| Patient Acceptance of Health Care | Major topic |
| Humans | |
| Female | |
| Genetic Predisposition to Disease | |
| Ovarian Neoplasms | |
| Anxiety | |
| Breast Neoplasms | |
| Depression |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42512355 | Evaluation of Costs, Efficiency and Performance of a Pilot Genetic Testing Traceback Program for Ovarian Cancer. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42512355 | PubMed |
| 42410102 | A changed landscape: five-year retrospective on the paradigm shift in genetic testing practices for ALS in Canada. | Eur J Hum Genet | 2026 | https://conductscience.org/library/papers/42410102 | PubMed |
| 42234943 | Communication With Clinicians and Relatives About Cascade Genetic Testing in Cancer Patients With Germline Pathogenic Variants. | JCO Precis Oncol | 2026 | https://conductscience.org/library/papers/42234943 | PubMed |
| 42104307 | Experiences accessing and receiving tumour genetic profiling in Victoria: a consumer-led cross-sectional survey study. | BMC Cancer | 2026 | https://conductscience.org/library/papers/42104307 | PubMed |
| 42032667 | Breast cancer specialists' experiences and attitudes towards mainstream genetic testing for patients with breast cancer. | Hered Cancer Clin Pract | 2026 | https://conductscience.org/library/papers/42032667 | PubMed |
| 41212395 | A Systematic Review of Patient-Reported Measures for Individuals Who Underwent Genetic Testing for Heritable Cancer. | Patient | 2026 | https://conductscience.org/library/papers/41212395 | PubMed |
| 40853717 | An eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Predisposition in Patients With Metastatic Cancers: Protocol for a Randomized Trial. | JMIR Res Protoc | 2025 | https://conductscience.org/library/papers/40853717 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40280545
GET https://conductscience.org/api/papers/v1/40280545/authors